REMSleep Holdings Inc RMSL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMSL is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.01 / $0.02
- Market Cap
- $14.62 Mil
- Volume/Avg
- 1.3 Mil / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 70.22
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The group offers the product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group functions through the region of the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
- Website
- https://www.remsleep.com
Valuation
|
Metric
|
RMSL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 15.44 |
Price/Sales | 70.22 |
Price/Cash Flow | — |
Price/Earnings
RMSL
Financial Strength
|
Metric
|
RMSL
|
|---|---|
Quick Ratio | 4.92 |
Current Ratio | 9.57 |
Interest Coverage | −88.26 |
Quick Ratio
RMSL
Profitability
|
Metric
|
RMSL
|
|---|---|
Return on Assets (Normalized) | −42.03% |
Return on Equity (Normalized) | −50.33% |
Return on Invested Capital (Normalized) | −43.96% |
Return on Assets
RMSL
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Hvbcqdkg | Ndmzlm | $185.5 Bil | |
SYK
| Stryker Corp | Thlqdlkc | Jjtr | $128.2 Bil | |
MDT
| Medtronic PLC | Wzsnmxhs | Tcyhwv | $106.7 Bil | |
BSX
| Boston Scientific Corp | Pdjzynvs | Ctfhv | $99.0 Bil | |
DXCM
| DexCom Inc | Xbdkqffyf | Gryrh | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Slcbnlpxm | Rncptbn | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jytrxhzb | Fdb | $24.9 Bil | |
ALGN
| Align Technology Inc | Jjdklkt | Fcsbxt | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Dsbmrygxg | Zvtppz | $18.9 Bil | |
PODD
| Insulet Corp | Xphphjzjy | Ptcxf | $11.7 Bil |